Infant dialysis—what makes it special?

2012 ◽  
Vol 9 (1) ◽  
pp. 15-17 ◽  
Author(s):  
Lesley Rees
Keyword(s):  
1996 ◽  
Vol 16 (1_suppl) ◽  
pp. 505-509 ◽  
Author(s):  
Timothy E. Bunchman

The proper treatment of an infant with end-stage renal disease depends upon a number of factors including parental willingness to take on the task, experience of the health-care team, local and regional resources, and society's willingness to accept this support as a standard of care. Whereas the abilityto keep infants aliveon peritoneal dialysis (PD) is obtainable, it is not without physical, financial, as well as emotional cost. In order for a family to agree to take on such a task, an understanding of the risks and long-term prognosis should be offered. This “informed consent” is difficult to obtain in such a highly charged situation when emotions often dictate choice independently of logic. Long-term outcome of infants on PD has improved over time, yet is still fraught with complications. Options of treatment or nontreatment are explored.


2012 ◽  
Vol 28 (10) ◽  
pp. 1943-1947 ◽  
Author(s):  
John D. Lantos ◽  
Bradley A. Warady
Keyword(s):  

2007 ◽  
Vol 17 (6) ◽  
pp. 66-66
Author(s):  
J. Sherbotie
Keyword(s):  

2021 ◽  
Vol 5 (1) ◽  
pp. e001224
Author(s):  
Heather J Lambert ◽  
Shriya Sharma ◽  
John N S Matthews

IntroductionThe I-KID study aims to determine the clinical efficacy, outcomes and safety of a novel non-CE-marked infant haemodialysis machine, the Newcastle Infant Dialysis Ultrafiltration System (NIDUS), compared with currently available therapy in the UK. NIDUS is specifically designed for renal replacement therapy in small babies between 0.8 and 8 kg.Methods and analysisThe clinical investigation is taking place in six UK centres. This is a randomised clinical investigation using a cluster stepped-wedge design. The study aims to recruit 95 babies requiring renal replacement therapy in paediatric intensive care units over 20 months.Ethics and disseminationThe study has high parent and public involvement at all stages in its design and parents will be involved in dissemination of results to parents and professionals via publications, conference proceedings and newsletters. The study has has ethics permissions from Tyne and Wear South Research Ethics Committee.Trial registration numbersIRAS ID number: 170 481MHRA Reference: CI/2017/0066ISRCT Number: 13 787 486CPMS ID number: 36 558NHS REC reference: 16/NE/0008Eudamed number: CIV-GB-18-02-023105Link to full protocol v6.0: https://fundingawards.nihr.ac.uk/award/14/23/26


2009 ◽  
Vol 155 (1) ◽  
pp. 111-117 ◽  
Author(s):  
Rana Hijazi ◽  
Carolyn L. Abitbol ◽  
Jayanthi Chandar ◽  
Wacharee Seeherunvong ◽  
Michael Freundlich ◽  
...  

2021 ◽  
pp. 1-14
Author(s):  
Lesley Rees ◽  
Motoshi Hattori ◽  
Dagmara Borzych-Dużałka
Keyword(s):  

2021 ◽  
Author(s):  
Heather Lambert ◽  
Shriya Sharma ◽  
John Matthews ◽  

Abstract Introduction: The I-KID study aims to determine the clinical efficacy, outcomes and safety of a novel non-CE-marked infant haemodialysis machine, the Newcastle Infant Dialysis Ultrafiltration System (NIDUS), compared to currently available therapy in the UK. NIDUS is specifically designed for renal replacement therapy in small babies between 0.8 and 8 kilograms. Methods and analysis: The clinical investigation is taking place in six UK centres. This is a randomised clinical investigation using a cluster stepped-wedge design. The study aims to recruit 95 babies requiring renal replacement therapy in paediatric intensive care units over 20 months.


2000 ◽  
Vol 136 (1) ◽  
pp. 1-2 ◽  
Author(s):  
Timothy E. Bunchman
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document